Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
VRX [NYSE]
Valeant Pharmaceuticals International, Inc.
Index- P/E- EPS (ttm)-2.25 Insider Own2.30% Shs Outstand333.96M Perf Week7.42%
Market Cap43.12B Forward P/E13.48 EPS next Y9.58 Insider Trans7.02% Shs Float325.67M Perf Month1.04%
Income-746.30M PEG- EPS next Q1.99 Inst Own66.80% Short Float4.57% Perf Quarter4.53%
Sales7.53B P/S5.72 EPS this Y-610.50% Inst Trans21.22% Short Ratio5.22 Perf Half Y-3.28%
Book/sh15.68 P/B8.24 EPS next Y19.26% ROA-2.70% Target Price52.38 Perf Year12.98%
Cash/sh1.59 P/C81.18 EPS next 5Y25.32% ROE-14.60% 52W Range102.60 - 153.10 Perf YTD9.99%
Dividend- P/FCF43.98 EPS past 5Y-33.00% ROI-0.10% 52W High-15.66% Beta0.90
Dividend %- Quick Ratio1.70 Sales past 5Y50.10% Gross Margin68.00% 52W Low25.86% ATR4.53
Employees17200 Current Ratio2.10 Sales Q/Q86.30% Oper. Margin16.10% RSI (14)59.93 Volatility3.29% 3.56%
OptionableYes Debt/Eq3.30 EPS Q/Q1064.80% Profit Margin-9.90% Rel Volume0.64 Prev Close128.02
ShortableYes LT Debt/Eq3.24 EarningsMay 08 BMO Payout- Avg Volume2.85M Price129.13
Recom3.00 SMA203.62% SMA507.02% SMA2001.25% Volume1,831,757 Change0.87%
28-Feb-14Reiterated UBS Buy $141 → $170
28-Feb-14Reiterated RBC Capital Mkts Outperform $151 → $158
27-Feb-14Reiterated Aegis Capital Buy $160 → $180
08-Jan-14Reiterated UBS Buy $125 → $141
08-Jan-14Reiterated Ladenburg Thalmann Buy $123 → $155
08-Jan-14Reiterated FBR Capital Outperform $130 → $153
03-Dec-13Reiterated UBS Buy $115 → $125
01-Nov-13Reiterated Ladenburg Thalmann Buy $127 → $123
30-Oct-13Initiated FBR Capital Outperform $130
07-Oct-13Reiterated CRT Capital Buy $110 → $130
08-Aug-13Reiterated UBS Buy $96 → $115
07-Aug-13Reiterated Aegis Capital Buy $135 → $140
02-Jul-13Reiterated RBC Capital Mkts Outperform $76 → $100
10-Jun-13Upgrade CRT Capital Hold → Buy $100
29-May-13Reiterated Ladenburg Thalmann Buy $84 → $124
29-May-13Reiterated Deutsche Bank Buy $82 → $103
03-May-13Reiterated Deutsche Bank Buy $80 → $82
04-Apr-13Reiterated UBS Buy $83 → $81
04-Apr-13Reiterated RBC Capital Mkts Outperform $80 → $76
21-Mar-13Reiterated Deutsche Bank Buy $77 → $83
24-Oct-14 05:50PM  Can Fat-Freezer Zeltiq Aesthetics Heat Up Profits? at Investor's Business Daily
05:00PM  Why Highbridge Capital sells stake in FirstEnergy Corp. Market Realist
04:51PM  VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
04:39PM  Botox Maker Allergan Pleaded for Goldmans Help in Valeant Fight at New York Times
10:05AM  What Does ValueAct See in Taking an Activist Role in Fertilizers? at 24/7 Wall St.
09:00AM  Why Highbridge Capital buys a new position in Tyson Foods Market Realist
23-Oct-14 05:00PM  Why Highbridge Capital buys a new stake in PVH Corp. Market Realist
01:00PM  Why Highbridge Capital opens a new stake in IBM Market Realist
09:00AM  Why Highbridge initiates a new position in Valeant Pharmaceuticals Market Realist
08:05AM  Valeant (VRX) Beats Earnings Estimates in Q3, Shares Gain Zacks
21-Oct-14 03:04PM  Allergan keeps a few secrets, court filing shows at MarketWatch
01:09PM  Midday movers: FedEx, KB Home, Waters & more at CNBC
12:42PM  Meister wants Allergan to sell for highest price CNBC
09:40AM  Will This Price Target Increase Help Valeant Pharmaceuticals (VRX) Stock Today? at TheStreet
20-Oct-14 07:39PM  Valeant hints at higher bid for Allergan at Financial Times
06:47PM  Can Valeant's Strong Q3 Entice Allergan? at Investor's Business Daily
06:05PM  After Tax Inversion Rules Change, AbbVie and Shire Agree to Terminate Their Deal at New York Times
04:45PM  VALEANT PHARMACEUTICALS INTL (VRX) Earnings Report: Q3 2014 Conference Call Transcript at TheStreet
03:31PM  Paulsons Hedge Fund Urges Botox-Maker Allergan to Consider Buying Shire at New York Times
03:13PM  Allergan files rebuttal to Valeant earnings at MarketWatch
01:52PM  Paulson & Co. pushes for Allergan merger with Shire: report at MarketWatch
12:52PM  IBM weighs heavily on the Dow at Financial Times
12:15PM  [video] Report: Paulson pushing Allergan-Shire merger at CNBC
11:45AM  Jim Cramer: Valeant Pharmaceuticals and Allergan Are Winners at TheStreet
10:48AM  [$$] Valeant Pushes Business Strength at The Wall Street Journal
10:44AM  [video]Stock Market Today: Dow Falls, Broader Market Rises as IBM Cuts Outlook at TheStreet
10:02AM  Strong On High Volume: Valeant Pharmaceuticals International (VRX) at TheStreet
09:58AM  Stock Market Today: Dow Falls as IBM Cuts Its Profit Outlook at TheStreet
09:55AM  [video] Cramer's Stop Trading: Valeant & Allergan at CNBC
09:38AM  Stocks to Watch: IBM, NCR, Halliburton at The Wall Street Journal
09:12AM  Morning Movers: IBM Sinks Dow Industrial Average; Halliburton Jumps on Earnings Beat at Barrons.com
07:43AM  Early Movers: IBM, VFC, HAL, VRX, HAS, YHOO & more at CNBC
07:22AM  [video] Valeant's bid for Allergan at CNBC
07:21AM  [video] Valiant effort by Valeant, Q3 beats estimates at CNBC
07:06AM  VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financ EDGAR Online
07:00AM  Valeant Pharmaceuticals Reports Third Quarter 2014 Financial Results PR Newswire
07:00AM  Valeant Pharmaceuticals Reports Third Quarter 2014 Financial Results CNW Group
05:09AM  Premarkets: 4 things to know before the open at CNNMoney.com
17-Oct-14 09:42AM  [video] Faber Report: Allergan takeover battle at CNBC
16-Oct-14 12:37PM  Ackman: Allergan tried to manipulate Valeant stock CNBC
12:37PM  [video] Ackman: Allergan tried to manipulate Valeant stock at CNBC
11:10AM  Will Actavis Win Competition For Allergan's Affection? Benzinga
12:00AM  AbbVie Cold Feet on Deal Shows Some Too Late to Invert at Bloomberg
15-Oct-14 09:17AM  Valeant Pharmaceuticals To Announce 2014 Third Quarter Results On October 20, 2014 PR Newswire
09:17AM  Valeant Pharmaceuticals To Announce 2014 Third Quarter Results On October 20, 2014 CNW Group
13-Oct-14 12:22PM  Ackman, others seek what Buffett has probably in vain Yahoo Finance
09:19AM  Bill Ackman's new fund falls 6% in public debut in Amsterdam MarketWatch
09:19AM  Bill Ackman's new fund falls 6% in public debut in Amsterdam at MarketWatch
06:43AM  [video] Bill Ackman: Venezuela Could Kill Herbalife's Earnings at Bloomberg
10-Oct-14 04:20PM  Allergan Raises Outlook amidst Valeant Takeover Attempts Zacks
09-Oct-14 07:00PM  Endo Buyout Of Auxilium Joins Two Changing Firms at Investor's Business Daily
06:25PM  Cramer: Activists are picking on the wrong chiefs at CNBC
05:30PM  Salix's Rectal Foam Uceris Receives Final FDA Approval Zacks
04:16PM  Bears Regain Control As Stocks Suffer Sharp Losses at Investor's Business Daily
12:59PM  Midday movers: Tesla, Apple, Yelp & more at CNBC
11:56AM  Allergan Steeply Raises Guidance, Taunts Valeant at Investor's Business Daily
10:51AM  Takeover target Allergan raises guidance at Financial Times
09:40AM  [video] Faber Report: Allergan updates guidance at CNBC
09:39AM  Company News for October 09, 2014 Zacks
08:28AM  How Will Allergan (AGN) Stock React Today to This Analyst Initiation? at TheStreet
06:34AM  Allergan, Inc Up As Deutsche Bank Initiates Coverage With Buy Rating Benzinga
08-Oct-14 05:19PM  [video] The Top Ten Stocks for Oct. 8 at Bloomberg
01:30PM  Allergan: Three's Company at Financial Times
01:04PM  3 Stocks Pushing The Drugs Industry Lower at TheStreet
09:53AM  Allergan & Valeant & Actavis & Salix: Can This Love Quadrilateral Work? at Barrons.com
09:42AM  Stocks to Watch: Allergan, Monstano, Costco at The Wall Street Journal
09:38AM  [video] Faber Report: Allergan news & noise at CNBC
09:35AM  Valeant Pharmaceuticals (VRX) Upgraded From Hold to Buy at TheStreet
09:05AM  Yum China sales not so yummy; Costco tops estimates; Symantec jumps on breakup talk Hot Stock Minute
09:01AM  Stock Futures Aim For A Bounce; Symantec Up On Split Reports at Investor's Business Daily
08:19AM  Morning Movers: Taser Gains on Camera Orders; Allergan Jumps as Valeant Ups Bid at Barrons.com
07:57AM  Investors look to Fed minutes; Yum's profits slammed; Twitter sues U.S. Hot Stock Minute
07:48AM  Early movers: JCP, COST, CMI, GRUB, KRFT, YUM at CNBC
07-Oct-14 07:33PM  Salix, Actavis Among Big Cap Pharmas In Merger Mambo at Investor's Business Daily
07:10PM  Valeant and Pershing Square to Raise Offer for Botox Maker Allergan at New York Times
07:07PM  Valeant Said to Plan on Raising Allergan Bid Near December Vote at Bloomberg
06:33PM  Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene at Investor's Business Daily
05:58PM  DJ: Valeant & Pershing to boost Allergan bid CNBC
05:58PM  [video] DJ: Valeant & Pershing to boost Allergan bid at CNBC
05:48PM  Valeant to boost Allergan bid by $15 a share: report at MarketWatch
01:57PM  [video] Allergan Asks Judge to Block Ackman From Voting Stock at Meeting at TheStreet
08:02AM  Video: GoPro Among Top 6 Stocks Beating The Market at Investor's Business Daily
07:45AM  Sirona Biochem: Obagi Medical Products Begins Manufacturing Scale-Up of Skin Lightening Agent Marketwired
03-Oct-14 02:39PM  Jazz Pharmaceuticals Uses New Cash To Buy For Growth at Investor's Business Daily
12:07PM  Salix Seen as Target After Scrapping Tax Inversion Cosmo Purchase at TheStreet
10:48AM  Salix pulls deal amid US tax crackdown at Financial Times
02-Oct-14 10:50PM  Push by Allergan to Acquire Salix Loses Steam at New York Times
06:53PM  What Sectors Sizzle As M&A Deals Notch New Boom Year? at Investor's Business Daily
01:11PM  Pharma love triangle is a win, win, win for investors at MarketWatch
01-Oct-14 07:00PM  Cramer's Message To EBAY And ANGI CNBC
07:00PM  [video] Cramer's Message To EBAY And ANGI at CNBC
12:45PM  Proxy Advisory Firm Seeks Shareholder Vote at Allergan, Maker of Botox at New York Times
12:02PM  Allergan pressed to have shareholder vote on Salix bid at Financial Times
09:35AM  ISS to Allergan: Let shareholders be heard CNBC
09:35AM  [video] ISS to Allergan: Let shareholders be heard at CNBC
05:04AM  Ackman Fund Raises More Than $3 Billion in Amsterdam I.P.O. at New York Times
30-Sep-14 11:27AM  Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA PR Newswire
11:27AM  Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA CNW Group
11:10AM  Valeant's Bausch + Lomb Announces Results on Lotemax Zacks
29-Sep-14 06:32PM  Large-Cap Tech, Biotech Names Hang Tough In Shaky Market at Investor's Business Daily
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter (OTC) products, and medical devices in the areas of eye health, dermatology, and neurology therapeutic classes worldwide. Its pharmaceutical products include Solodyn, an oral antibiotic that treats red and pus-filled pimples, as well as Ziana, Acanya, and Atralin; Wellbutrin XL, a formulation used for the treatment of major depressive disorder in adults; Xenazine for the treatment of chorea; Zovirax Cream for herpes labialis; Zovirax ointment for initial genital herpes; The Lotemax gel for post-operative inflammation and pain; Arestin, a subgingival sustained-release antibiotic; and Prolensa, a non-steroidal anti-inflammatory ophthalmic solution. The company also provides OTC products, such as PreserVision, an antioxidant eye vitamin and mineral supplement; ReNu Multiplus, a sterile that is used to lubricate and rewet soft contact lenses; Ocuvite, a lutein eye vitamin and mineral supplement; Artelac, an eye drops to treat dry eyes; and CeraVe products for skin. In addition, it offers device products, including SofLens daily disposable contact lenses; Restylane, an injectable implant dermal fillers; PureVision, a contact lens; Dysport, an injection neurotoxin; ophthalmic surgical products, such as Akreos and Crystalens; surgical equipment comprising the VICTUS femtosecond laser and the Stellaris PC, a vitreoretinal and cataract surgery system; and medical device systems for aesthetic applications. Further, it provides generic products comprising Retin-A Micro, a tretinoin gel; tobramycin and dexamethasone ophthalmic suspensions for steroid responsive inflammatory ocular conditions; and latanoprost to treat glaucoma. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. Valeant Pharmaceuticals International, Inc. was founded in 1983 and is headquartered in Laval, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stolz Brian M.EVP, Administration and CHCOOct 10Option Exercise0.003,675084,791Oct 14 02:51 PM
Schiller Howard BradleyEVP and CFOOct 03Option Exercise0.0022,5000285,500Oct 07 04:19 PM
Stolz Brian M.EVP, Administration and CHCOSep 30Option Exercise0.0023,030093,064Oct 02 03:52 PM
Stolz Brian M.EVP, CHCO and AdministrationAug 06Option Exercise0.0018,111079,431Aug 07 03:53 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.Jun 23Option Exercise6.4510,20365,80934,202Jun 24 04:37 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.Jun 23Sale121.7010,2031,241,67623,999Jun 24 04:37 PM
Mirovsky PavelPresident of Valeant EuropeJun 02Sale131.2510,0001,312,4860Jun 04 03:19 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.May 13Option Exercise6.4510,00064,50033,999May 14 04:29 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.May 13Sale130.0810,0001,300,83623,999May 14 04:29 PM
Provencio Norma AnnDirectorApr 01Sale132.185,000660,886137,495Apr 02 04:55 PM
Kornwasser LaizerEVP, Company Group ChairmanMar 21Buy134.972,481334,85953,582Mar 25 01:06 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.Mar 17Option Exercise6.455,00032,25028,999Mar 19 04:33 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.Mar 17Sale141.725,000708,60023,999Mar 19 04:33 PM
Weldon RyanEVP, Company Group ChairmanFeb 11Option Exercise0.0011,0000103,823Feb 12 04:43 PM
Stolz Brian M.EVP, Administration & CHCOFeb 11Option Exercise0.0014,700069,783Feb 12 04:08 PM
Schiller Howard BradleyEVP, CFOFeb 11Option Exercise0.0090,0000312,704Feb 12 03:51 PM
Kornwasser LaizerEVP, Company Group ChairmanFeb 11Option Exercise0.0045,000073,390Feb 12 03:34 PM
Provencio Norma AnnDirectorFeb 03Sale136.235,000681,158147,206Feb 04 06:15 PM
Weldon RyanEVP, Company Group ChairmanJan 24Option Exercise0.0019,0000101,539Jan 28 05:09 PM
Mirovsky PavelPresident of Valeant EuropeJan 24Option Exercise0.0010,000010,000Jan 28 05:00 PM
Kornwasser LaizerEVP, Company Group ChairmanJan 24Buy132.152,536335,12828,390Jan 28 04:51 PM
Stolz Brian M.EVP, Administration and CHCOJan 20Option Exercise0.0045,000077,939Jan 22 04:55 PM